MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Anxiety"

  • 2024 International Congress

    Assessment Of The Effect Of Sleep Deprivation And Essential Amino Acid Deficient Diet (Tryptophan) On Growth And Cognition In Wistar Rats

    L. Usman, R. Ibrahim, H. Abdulameed, E. Ajani, A. Akinmoladun (Kepala Batas, Malaysia)

    Objective: This study explores the interplay encompassing amino acids' roles, metabolic processes, growth, and the intricate relationships between sleep patterns, amino acid-deficient diet, and caffeine…
  • 2024 International Congress

    Improving Neuropsychiatric Comorbidity in Geriatric Spinocerebellar Ataxia

    M. Le, B. Carr (Gainesville, USA)

    Objective: This study evaluates neuropsychiatric comorbidity in spinocerebellar ataxia (SCA) and highlights key aspects of management in the geriatric population. It discusses efficacy of neuropsychotropic…
  • 2024 International Congress

    The assessment of anxiety and depression comorbidities and the DRN electrophysiology in a primate model of Parkinson’s Disease

    A. Sadoun, M. Deffains, Q. Li, E. Bezard, F. Georges, E. Pioli (Floirac, France)

    Objective: The study aimed to examine the anxiety/depression-like phenotype and the potential role of dorsal raphe nucleus (DRN) in the gold standard primate model of…
  • 2024 International Congress

    A Randomized, Double-Blind, Placebo-Controlled Trial of a Multi-Strain Probiotic for Anxiety in Parkinson’s Disease

    J. Lam, P. Uzelman, J. Zhu, D. Meng, F. Pio, S. Appel-Cresswell (Vancouver, Canada)

    Objective: To evaluate the effect of a multi-strain probiotic on anxiety in patients with Parkinson’s disease (PD). Background: There is a lack of dedicated randomized…
  • 2024 International Congress

    Investigating an Emerging Anxiety-like Phenotype in a Novel Bilateral Rodent Model of Parkinsonian Alpha-Synuclein Pathology

    N. Lipari, I. Sandoval, F. Manfredsson, C. Bishop (Binghamton, USA)

    Objective: Investigate an emerging anxiety-like phenotype at various timepoints in a novel bilateral rodent model of parkinsonian alpha-synuclein pathology. Background: Parkinson’s Disease (PD) anxiety poses…
  • 2024 International Congress

    Effect of Target Selection on Mood, Pain, and Medications after DBS in PD

    J. Jiao, B. Brumbach, Y. Lin, A. Ko, D. Safarpour (Palo Alto, USA)

    Objective: To describe the association between medication adjustments with mood and pain following bilateral deep brain stimulation (DBS) in Parkinson’s disease (PD). Background: Depression, anxiety,…
  • 2024 International Congress

    Unwinding Anxiety: Feasibility and Effectiveness of App-Based Mindfulness Training for People with Anxiety and Parkinson’s Disease: A Pilot Study

    E. Weisbach, A. Demarco, J. Molino, A. Seritan, P. Prakash (Providence, USA)

    Objective: To assess whether an app-based mindfulness training (MT) intervention, “Unwinding Anxiety”, can be used for Parkinson’s Disease (PD) patients with mild-moderate anxiety to reduce…
  • 2024 International Congress

    Nocturnal Blood Pressure, Non-Dipping, Psychosis And Non-Motor Symptoms In Early Stages Of Huntington’s Disease Patients

    R. Singh, V. Sharma (New Delhi, India)

    Objective: The aim of this study was to determine the relationship between 24 h ambulatory blood pressure measurements (ABPM), i.e., absence or presence of nocturnal…
  • 2024 International Congress

    Prevalence and characteristics of anxiety in Parkinson’s disease

    I. Murasan, S. Diaconu, L. Ungureanu, I. Despa, A. Zarnoveanu, B. Opritoiu, C. Falup-Pecurariu (Brasov, Romania)

    Objective: To evaluate the characteristics of anxiety in relation to motor and non-motor symptoms in a cohort of PD patients. Background: Anxiety is a frequent…
  • 2024 International Congress

    Measuring Cortisol Levels in Persons with Huntington’s Disease

    A. Clarke, B. Lobb, A. Hiller (Portland, USA)

    Objective: To assess subjective and objective measures of emotional stress via standardized scales and a physiological measure (salivary cortisol) in persons with Huntington’s Disease (HD)…
  • 1
  • 2
  • 3
  • …
  • 17
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Nilotinib for treating MSA: A preclinical proof of concept study
  • An atypical and interesting feature of Parkinson´s disease
  • Patients with Essential Tremor Live Longer than their Relatives
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • An atypical and interesting feature of Parkinson´s disease
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley